Cargando…
Randomized Phase III Trial of Piroxicam in Combination with Mitoxantrone or Carboplatin for First‐Line Treatment of Urogenital Tract Transitional Cell Carcinoma in Dogs
BACKGROUND: Reported response rates of transitional cell carcinoma (TCC) in dogs to piroxicam in combination with either mitoxantrone or carboplatin are similar; however, it is unknown whether either drug might provide superior duration of response. HYPOTHESIS/OBJECTIVES: To determine if the progres...
Autores principales: | Allstadt, S.D., Rodriguez, C.O., Boostrom, B., Rebhun, R.B., Skorupski, K.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858101/ https://www.ncbi.nlm.nih.gov/pubmed/25619518 http://dx.doi.org/10.1111/jvim.12533 |
Ejemplares similares
-
Bacterial Urinary Tract Infections Associated with Transitional Cell Carcinoma in Dogs
por: Budreckis, D.M., et al.
Publicado: (2015) -
Frequency and Severity of Neutropenia Associated with Food and Drug Administration Approved and Compounded Formulations of Lomustine in Dogs with Cancer
por: Burton, J.H., et al.
Publicado: (2016) -
Early Tumor Response to Intraarterial or Intravenous Administration of Carboplatin to Treat Naturally Occurring Lower Urinary Tract Carcinoma in Dogs
por: Culp, W.T.N., et al.
Publicado: (2015) -
Comparison of Carboplatin and Doxorubicin‐Based Chemotherapy Protocols in 470 Dogs after Amputation for Treatment of Appendicular Osteosarcoma
por: Selmic, L.E., et al.
Publicado: (2014) -
Histopathologic Variation between Liver Lobes in Dogs
por: Kemp, S.D., et al.
Publicado: (2015)